Hypoxia-inducible factor prolyl 4-hydroxylases:common and specific roles

Biological Chemistry

Volumn 394, Issue 4, 2013, Pages 435-448

  Myllyharju, Johanna ^a   Koivunen, Peppi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Anemia; Gene modified mice; Hypoxia; Hypoxia inducible factor; Ischemia; Prolyl 4 hydroxylase

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ARGININE; DIOXYGENASE; HISTIDINE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; IRON REGULATORY PROTEIN 2; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RNA POLYMERASE II;

ANGIOGENESIS; BINDING SITE; CELLULAR DISTRIBUTION; CRYSTALLIZATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; ERYTHROCYTOSIS; HUMAN; MAMMAL CELL; MUTATION; NEGATIVE FEEDBACK; NONHUMAN; OXYGEN THERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; RETROLENTAL FIBROPLASIA; REVIEW;

ANIMALS; ANOXIA; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE;

EID: 84882252310     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2012-0328     Document Type: Review

References (136)

1. Adluri, R.S., Thirunavukkarasu, M., Dunna, N.R., Zhan, L., Oriowo, B., Takeda, K., Sanchez, J.A., Otani, H., Maulik, G., Fong, G.H., et al. (2011). Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1 -/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxiainducible factor-1α transcription factor and its target genes in mice. Antioxid. Redox Signal. 15, 1789-1797.
2. Albiero, E., Ruggeri, M., Fortuna, S., Finotto, S., Bernardi, M., Madeo, D., and Rodeghier, F. (2012). Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Haematologica 97, 123-127.
3. Ameln, A.K., Muschter, A., Mamlouk, S., Kalucka, J., Prade, I., Franke, K., Rezaei, M., Poitz, D.M., Breier, G., and Wielockx, B. (2011). Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ. Cancer Res. 71, 3306-3316.
4. Appelhoff, R.J., Tian, Y.M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., and Gleadle, J.M. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465.
5. Aragonés, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkz, R., Zacchigna, S., Lemieux, H., Jeoung, N.H., et al. (2008). Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170-180.
6. Baranova, O., Miranda, L.F., Pichiule, P., Dragatsis, I., Johnson, R.S., and Chavez, J.C. (2007). Neuron-specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci. 27, 6320-6332.
7. Berra, E., Benizri, E., Ginouv è s, A., Volmat, V., Roux, D., and Pouysségur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082-4090.
8. Bishop, T., Gallagher, D., Pascual, A., Lygate, C.A., de Bono, J.P., Nicholls, L.G., Ortega-Saenz, P., Oster, H., Wijeyekoon, B., Sutherland, A.I., et al. (2008). Abnormal sympathoadrenal development and systemic hypotension in PHD3 -/- mice. Mol. Cell. Biol. 28, 3386-3400.
9. Bordoli, M.R., Stiehl, D.P., Borsig, L., Kristiansen, G., Hausladen, S., Schraml, P., Wenger, R.H., and Camenisch, G. (2011). Prolyl-4- hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene 30, 548-560.
10. Bruick, R.K. and McKnight, S.L. (2001). A conserved family of prolyl 4-hydroxylases that modify HIF. Science 294, 1337-1340.
11. Cai, Z., Zhong, H., Bosch-Marce, M., Fox-Talbot, K., Wang, L., Wei, C., Trush, M.A., and Semenza, G.L. (2008). Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α . Cardiovasc. Res. 77, 463-470.
12. Cervera, A.M., Apostolova, N., Luna-Crespo, F., Sanjuan-Pla, A., Garcia-Bou, R., and McCreath, K.J. (2006). An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity. Cancer Lett. 233, 131-138.
13. Chan, D.A., Suthpin, P.D., Yen, S.-E., and Giaccia, A.J. (2005). Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1α . Mol. Cell. Biol. 25, 6415-6426.
14. Chan, D.A., Kawahara, T.L., Sutphin, P.D., Chang, H.Y., Chi, J.T., and Giaccia, A.J. (2009). Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 15, 527-538.
15. Chen, R.L., Nagel, S., Papadakis, M., Bishop, T., Pollard, P., Ratcliffe, P.J., Pugh, C.W., and Buchan, A.M. (2012). Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice. J. Physiol. 590, 4079-4091.
16. Chowdhury, R., Hardy, A., and Schofield, C.J. (2008). The human oxygen sensing machinery and its manipulation. Chem. Soc. Rev. 37, 1308-1319.
17. Chowdhury, R., McDonough, M.A., Mecinovi?, J., Loenarz, C., Flashman, E., Hewitson, K.S., Domene, C., and Schofield, C.J. (2009). Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 17, 981-989.
18. Cummins, E.P., Berra, E., Comerford, K.M., Ginouves, A., Fitzgerald, K.T., Seeballuck, F., Godson, C., Nielsen, J.E., Moynagh, P., Pouyssegur, J., et al. (2006). Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl. Acad. Sci. USA 28, 18154-18159.
19. D'Angelo, G., Duplan, E., Boyer, N., Vigne, P., and Frelin, C. (2003). Hypoxia up-regulates prolyl hydroxylase activity. A feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278, 38183-38187.
20. del Peso, L., Castellanos, M.C., Temes, E., Martín-Puig, S., Cuevas, Y., Olmos, G., and Landazuri, M.O. (2003). The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690-48695.
21. Duan, L.J., Takeda, K., and Fong, G.H. (2011). Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice. Am. J. Pathol. 178, 1881-1890.
22. Eckle, T., Köhler, D., Lehmann, R., El Kasmi, K., and Eltzschig, H.K. (2008). Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118, 166-175.
23. Eckle, T., Hartmann, K., Bonney, S., Reithel, S., Mittelbronn, M., Walker, L.A., Lowes, B.D., Han, J., Borchers, C.H., Buttrick, P.M., et al. (2012). Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat. Med. 18, 774-782.
24. Ehrismann, D., Flashman, E., Genn, D.N., Mathioudakis, N., Hewitson, K.S., Ratcliffe, P.J., and Schofield, C.J. (2007). Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 401, 227-234.
25. Eltzschig, H.K. and Carmeliet, P. (2011). Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665.
26. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
27. Flashman, E., Bagg, E.A.L., Chowdhury, R., Mecinovic, J., Loenarz, C., McDonough, M.A., Hewitson, K.S., and Schofield, C.J. (2008). Kinetic rationale for selectivity towards N- and C-terminal oxygen dependent degradation domain substrates mediated by a loop region of HIF prolyl hydroxylases. J. Biol. Chem. 283, 3808-3815.
28. Fraisl, P., Aragonés, J., and Carmeliet, P. (2009). Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8, 139-152.
29. Ge, W., Wolf, A., Feng, T., Ho, C.H., Sekirnik, R., Zayer, A., Granatino, N., Cockman, M.E., Loenarz, C., Loik, N.D., et al. (2012). Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans. Nat. Chem. Biol., in press.
30. Gordan, J.D., Bertout, J.A., Hu, C.J., Diehl, J.A., and Simon, M.C. (2007). HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11, 335-347.
31. Greer, S.N., Metcalf, J.L., Wang, Y., and Ohh, M. (2012). The updated biology of hypoxia-inducible factor. EMBO J. 31, 2448-2460.
32. Grenz, A., Clambey, E., and Eltzschig, H.K. (2012). Hypoxia signaling during intestinal ischemia and inflammation. Curr. Opin. Crit. Care 18, 178-185.
33. Haase, V.H. (2010). Hypoxic regulation of erythropoiesis and iron metabolism. Am. J. Physiol. Renal Physiol. 299, F1-13.
34. Hanson, E.S., Rawlins, M.L., and Leibold, E.A. (2003). Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278, 40337-40342.
35. Harten, S.K., Ashcroft, M., and Maxwell, P.H. (2010). Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection. Antioxid. Redox Signal. 12, 459-480.
36. Heindryckx, F., Kuchnio, A., Casteleyn, C., Coulon, S., Olievier, K., Colle, I., Geerts, A., Libbrecht, L., Carmeliet, P., and Van Vlierberghe, H. (2012). Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice. J. Hepatol. 57, 61-68.
37. Hewitson, K.S., Liénard, B.M., McDonough, M.A., Clifton, I.J., Butler, D., Soares, A.S., Oldham, N.J., McNeill, L.A., and Schofield, C.J. (2007). Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 282, 3293-3301.
38. Hirsil ä, M., Koivunen, P., Günzler, V., Kivirikko, K.I., and Myllyharju, J. (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772-30780.
39. Hirsil ä, M., Koivunen, P., Xu, L., Seeley, T., Kivirikko, K.I., and Myllyharju, J. (2005). Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19, 1308-1310.
40. Hölscher, M., Silter, M., Krull, S., von Ahlen, M., Hesse, A., Schwartz, P., Wielockx, B., Breier, G., Katschinski, D.M., and Zieseniss, A. (2011). Cardiomyocyte-specific prolyl- 4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J. Biol. Chem. 286, 11185-11194.
41. Hon, W.C., Wilson, M.I., Harlos, K., Claridge, T.D., Schofield, C.J., Pugh, C.W., Maxwell, P.H., Ratcliffe, P.J., Stuart, D.I., and Jones, E.Y. (2002). Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417, 975-978.
42. Huang, M., Chan, D.A., Jia, F., Xie, X., Li, Z., Hoyt, G., Robbins, R.C., Chen, X., Giaccia, A.J., and Wu, J.C. (2008). Short hairpin RNA interference therapy for ischemic heart disease. Circulation 118, S226 - S233.
43. Huang, H., Van de Veire, S., Dalal, M., Parlier, R., Semba, R.D., Carmeliet, P., and Vinores, S.A. (2011). Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest. Ophthalmol. Vis. Sci. 52, 7565-7573.
44. Hyvärinen, J., Hassinen, I.E., Sormunen, R., Mäki, J.M., Kivirikko, K.I., Koivunen, P., and Myllyharju, J. (2010a). Hearts of hypoxiainducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J. Biol. Chem. 285, 13646-13657.
45. Hyvärinen, J., Parikka, M., Sormunen, R., Rämet, M., Tryggvason, K., Kivirikko, K.I., Myllyharju, J., and Koivunen, P. (2010b). Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function. J. Biol. Chem. 285, 42023-42032.
46. Illingworth, C.J.R., Loenarz, C., Schofield, C.J., and Domene, C. (2010). Chemical basis for the selectivity of the von Hippel Lindau tumor suppressor pVHL for prolyl-hydroxylated HIF-1α . Biochemistry 49, 6936-6944.
47. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J.M., Lanie, W.S., and Kaelin, W.G., Jr. (2001). HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O 2 sensing. Science 292, 464-468.
48. Ivan, M., Haberberger, T., Gervasi, D.C., Michelson, K.S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R.C., Conaway, J.W., et al. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxiainducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
49. Jaakkola, P., Mole, D.R., Tian, Y.-M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Kriegsheim, A.V., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O 2 -regulated prolyl hydroxylation. Science 292, 468-472.
50. Jokilehto, T. and Jaakkola, P.M. (2010). The role of HIF prolyl hydroxylases in tumour growth. J. Cell. Mol. Med. 14, 758-770.
51. Kaelin, W.G. Jr. (2008). The von Hippel-Lindau tumour suppressor protein: O 2 sensing and cancer. Nat. Rev. Cancer 8, 865-873.
52. Kaelin, W.G. Jr. and Ratcliffe, P.J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
53. Kapitsinou, P.P., Liu, Q., Unger, T.L., Rha, J., Davidoff, O., Keith, B., Epstein, J.A., Moores, S.L., Erickson-Miller, C.L., and Haase, V.H. (2010). Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116, 3039-3048.
54. Keith, B. and Simon, M.C. (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465-472.
55. Keith, B., Johnson, R.S., and Simon, M.C. (2011). HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12, 9-22.
56. Kiss, J., Mollenhauer, M., Walmsley, S.R., Kirchberg, J., Radhakrishnan, P., Niemietz, T., Dudda, J., Steinert, G., Whyte, M.K., Carmeliet, P., et al. (2012). Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. J. Immunol. 189, 1955-1965.
57. Klotzsche-von Ameln, A., Muschter, A., Heimesaat, M.M., Breier, G., and Wielockx, B. (2012). HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinaseinduced TGFβ activation. Cancer Biol. Ther. 13, 216-223.
58. Köditz, J., Nesper, J., Stiehl, D.P., Camenisch, G., Franke, C., Myllyharju, J., Wenger, R.H., and Katschinski, D.M. (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110, 3610-3617.
59. Koivunen, P., Hirsil ä, M., Kivirikko, K.I., and Myllyharju, J. (2006). The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J. Biol. Chem. 281, 28712-28720.
60. Koivunen, P., Hirsil ä, M., Remes, A.M., Hassinen, I.E., Kivirikko, K.I., and Myllyharju, J. (2007a). Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates. Possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282, 4524-4532.
61. Koivunen, P., Tiainen, P., Hyvärinen, J., Williams, K.E., Sormunen, R., Klaus, S.J., Kivirikko, K.I., and Myllyharju, J. (2007b). An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factorα. J. Biol. Chem. 282, 30544-30552.
62. Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012). Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484-488.
63. Koshiji, M., Kageyama, Y., Pete, E.A., Horikawa, I., Barrett, J.C., and Huang, L.E. (2004). HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23, 1949-1956.
64. Kunze, R., Zhou, W., Veltkamp, R., Wielockx, B., Breier, G., and Marti, H.H. (2012). Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke 43, 2748-2756.
65. Kuznetsova, A.V., Meller, J., Schnell, P.O., Nash, J.A., Ignacak, M.L., Sanchez, Y., Conaway, J.W., Conaway, R.C., and Czyzyk- Krzeska, M.F. (2003). von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc. Natl. Acad. Sci. USA 100, 2706-2711.
66. Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., and Gardie, B. (2008). PHD2 mutation and congenital erythrocytosis with paraganglioma. N. Engl. J. Med. 359, 2685-2692.
67. Ladroue, C., Hoogewijs, D., Gad, S., Carcenac, R., Storti, F., Barrois, M., Gimenez-Roqueplo, A.P., Leporrier, M., Casadevall, N., Hermine, O., et al. (2012). Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Haematologica 97, 9-14.
68. Laitala, A., Aro, E., Walkinshaw, G., Mäki, J.M., Rossi, M., Heikkil ä, M., Savolainen, E.-R., Arend, M., Kivirikko, K.I., Koivunen, P., et al. (2012). Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. Blood 120, 3336-3344.
69. Lee, F.S. and Percy, M.J. (2011) The HIF pathway and erythrocytosis. Annu. Rev. Pathol. 6, 165-192.
70. Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M.S., Sajan, M.P., Farese, R.V., Freeman, R.S., Carter, B.D., Kaelin, W.G. Jr., et al. (2005). Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8, 155-167.
71. Leite de Oliveira, R., Deschoemaeker, S., Henze, A.T., Debackere, K., Finisguerra, V., Takeda, Y., Roncal, C., Dettori, D., Tack, E., Jönsson, Y., et al. (2012). Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 22, 263-277.
72. Li, N., Yi, F., Sundy, C.M., Chen, L., Hilliker, M.L., Donley, D.K., Muldoon, D.B., and Li, P.L. (2007). Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am. J. Physiol. Renal Physiol. 292, F207 - F216.
73. Lieb, M.E., Menzies, K., Moschella, M.C., Ni, R., and Taubman, M.B. (2002). Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell. Biol. 80, 421-426.
74. Loenarz, C. and Schofield, C.J. (2011). Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36, 7-18.
75. Loinard, C., Ginouv è s, A., Vilar, J., Cochain, C., Zouggari, Y., Recalde, A., Duriez, M., Lévy, B.I., Pouysségur, J., Berra, E., et al. (2009). Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 120, 50-59.
76. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R.N., Pandey, A., and Semenza, G.L. (2011). Pyruvate kinase M2 is a PHD3-stimukated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744.
77. Macdougall, I.C. (2012). New anemia therapies: translating novel strategies from bench to bedside. Am. J. Kidney Dis. 59, 444-451.
78. Majmundar, A.J., Wong, W.J., and Simon, M.C. (2010). Hypoxiainducible factors and the response to hypoxic stress. Mol. Cell 40, 294-309.
79. Marxsen, J.H., Stengel, P., Doege, K., Heikkinen, P., Jokilehto, T., Wagner, T., Jelkmann, W., Jaakkola, P., and Metzen, E. (2004). Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4- hydroxylases. Biochem. J. 381, 761-767.
80. Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A.A., Pollard, P., Ruiz de Almodovar, C., et al. (2009). Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851.
81. McDonough, M.A., Li, V., Flashman, E., Chowdhury, R., Mohr, C., Liénard, B.M., Zondlo, J., Oldham, N.J., Clifton, I.J., Lewis, J., et al. (2006). Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc. Natl. Acad. Sci. USA 103, 9814-9819.
82. McDonough, M.A., Loenarz, C., Chowdhury, R., Clifton, I.J., and Schofield, C.J. (2010). Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 20, 659-672.
83. McNeill, L.A., Flashman, E., Buck, M.R.G., Hewitson, K.S., Clifton, I.J., Jeschke, G., Glaridge, T.D., Ehrismann, D., Oldham, N.J., and Schofield, C.J. (2005). Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol. Biosyst. 1, 321-324.
84. Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J.H., Stolze, I., Klinger, M., Huang, W.Q., Wotzlaw, C., Hellwig- Bürgel, T., Jelkmann, W., et al. (2003). Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
85. Metzen, E., Stiehl, D.P., Doege, K., Marxsen, J.H., Hellwig-Bürgel, T., and Jelkmann, W. (2005). Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem. J. 387, 711-717.
86. Mikhaylova, O., Ignacak, M.L., Barankiewicz, T.J., Harbaugh, S.V., Yi, Y., Maxwell, P.H., Schneider, M., Van Geyte, K., Carmeliet, P., Revelo, M.P., et al. (2008). The von Hippel-Lindau tumor suppressor protein and Egl-9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol. Cell. Biol. 28, 2701-2717.
87. Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W.G. Jr., and Pavletich, N.P. (2002). Structure of an HIF-1α -pVHL complex: hydroxyproline recognition and signaling. Science 296, 1886-1889.
88. Minamishima, Y.A. and Kaelin, W.G., Jr. (2010). Reactivation of hepatic EPO synthesis in mice after PHD loss. Science 329, 407.
89. Minamishima, Y.A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R.T., and Kaelin, W.G. Jr. (2008). Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111, 3236-3244.
90. Minamishima, Y.A., Moslehi, J., Padera, R.F., Bronson, R.T., Liao, R., and Kaelin, W.G. Jr. (2009). A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol. Cell. Biol. 29, 5729-5741.
91. Mollenhauer, M., Kiss, J., Dudda, J., Kirchberg, J., Rahbari, N., Radhakrishnan, P., Niemietz, T., Rausch, V., Weitz, J., and Schneider, M. (2012). Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy. Langenbecks Arch. Surg. in press.
92. Moslehi, J., Minamishima, Y.A., Shi, J., Neuberg, D., Charytan, D.M., Padera, R.F., Signoretti, S., Liao, R., and Kaelin, W.G. Jr. (2010). Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 122, 1004-1016.
93. Myllyharju, J. (2008). Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets. Ann. Med. 40, 402-417.
94. Myllyharju, J. (2009). HIF prolyl 4-hydroxylases and their potential as drug targets. Curr. Pharm. Des. 15, 3878-3885.
95. Myllyharju, J. (2012). Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiol. (Oxf.) in press.
96. Myllyharju, J. and Schipani, E. (2010). Extracellular matrix genes as hypoxia-inducible targets. Cell Tissue Res. 339, 19-29.
97. Nagel, S., Talbot, N.P., Mecinovi?, J., Smith, T.G., Buchan, A.M., and Schofield, C.J. (2010). Therapeutic manipulation of the HIF hydroxylases. Antioxid. Redox Signal. 12, 481-501.
98. Nizet, V. and Johnson, R.S. (2009). Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609-617.
99. Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T.J., Ramakrishnan, S., Hütter, J., Schramm, M., and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
100. Ozer, A. and Bruick, R.K. (2007). Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat. Chem. Biol. 3, 144-153.
101. Pajusola, K., Künnapuu, J., Vuorikoski, S., Soronen, J., André, H., Pereira, T., Korpisalo, P., Ylä-Herttuala, S., Poellinger, L., and Alitalo, K. (2005). Stabilized HIF-1α is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J. 19, 1365-1367.
102. Patel, S.A. and Simon, M.C. (2008). Biology of hypoxia-inducible factor-2α in development and disease. Cell Death Differ. 15, 628-634.
103. Percy, M.J., Zhao, Q., Flores, A., Harrison, C., Lappin, T.R.J., Maxwell, P.H., McMullin, M.F., and Lee, F.S. (2006). A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. USA 103, 654-659.
104. Percy, M.J., Furlow, P.W., Beer, P.A., Lappin, T.R., McMullin, M.F., and Lee, F.S. (2007). A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 11, 2193-2196.
105. Peurala, E., Koivunen, P., Bloigu, R., Haapasaari, K.M., and Jukkola- Vuorinen, A. (2012). Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients. Breast Cancer Res. Treat. 133, 179-188.
106. Rankin, E.B. and Giaccia, A.J. (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15, 678-685.
107. Rankin, E.B., Wu, C., Khatri, R., Wilson, T.L., Andersen, R., Araldi, E., Rankin, A.L., Yuan, J., Kuo, C.J., Schipani, E., et al. (2012). The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 149, 63-74.
108. Rey, S., Lee, K., Wang, C.J., Gupta, K., Chen, S., McMillan, A., Bhise, N., Levchenko, A., and Semenza, G.L. (2009). Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrowderived angiogenic cells in a mouse model of limb ischemia. Proc. Natl. Acad. Sci. USA 106, 20399-20404.
109. Sarkar, K., Fox-Talbot, K., Steenbergen, C., Bosch-Marc é, M., and Semenza, G.L. (2009). Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice. Proc. Natl. Acad. Sci. USA 106, 18769-18774.
110. Sarkar, K., Cai, Z., Gupta, R., Parajuli, N., Fox-Talbot, K., Darshan, M.S., Gonzalez, F.J., and Semenza, G.L. (2012). Hypoxiainducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc. Natl. Acad. Sci. USA 109, 10504-10509.
111. Schlisio, S., Kenchappa, R.S., Vredeveld, L.C., George, R.E., Stewart, R., Greulich, H., Shahriari, K., Nguyen, N.V., Pigny, P., Dahia, P.L., et al. (2008). The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22, 884-893.
112. Schneider, M., Van Geyte, K., Fraisl, P., Kiss, J., Aragonés, J., Mazzone, M., Mairbäurl, H., De Bock, K., Jeoung, N.H., Mollenhauer, M., et al. (2010). Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/ reperfusion injury. Gastroenterology 138, 1143-1154.
113. Schödel, J., Klanke, B., Weidemann, A., Buchholz, B., Bernhardt, W., Bertog, M., Amann, K., Korbmacher, C., Wiesener, M., Warnecke, C., et al. (2009). HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am. J. Pathol. 174, 1663-1674.
114. Semenza, G.L. (2011). Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 365, 537-547.
115. Semenza, G.L. (2012a). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
116. Semenza, G.L. (2012b). Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33, 207-214.
117. Shen, C. and Kaelin, W.G., Jr. (2012). The VHL/HIF axis in clear cell renal carcinoma. Semin. Cancer Biol. in press.
118. Stiehl, D.P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., and Wenger, R.H. (2006). Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491.
119. Takeda, K., Ho, V.C., Takeda, H., Duan, L.-J., Nagy, A., and Fong, G.-H. (2006). Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26, 8336-8346.
120. Takeda, K., Cowan, A., and Fong, G.-H. (2007). Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116, 774-781.
121. Takeda, K., Aguila, H.L., Parikh, N.S., Li, X., Lamothe, K., Duan, L.-J., Takeda, H., Lee, F.S., and Fong, G-H. (2008). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111, 3229-3235.
122. Takeda, Y., Costa, S., Delamarre, E., Roncal, C., Leite de Oliveira, R., Squadrito, M.L., Finisguerra, V., Deschoemaeker, S., Bruy è re, F., Wenes, M., et al. (2011). Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479, 122-126.
123. Tambuwala, M.M., Cummins, E.P., Lenihan, C.R., Kiss, J., Stauch, M., Scholz, C.C., Fraisl, P., Lasitschka, F., Mollenhauer, M., Saunders, S.P., et al. (2010). Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139, 2093-2101.
124. Tian, Y.M., Mole, D.R., Ratcliffe, P.J., and Gleadle, J.M. (2006). Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation. Biochem. J. 397, 179-186.
125. Tian, Y.M., Yeoh, K.K., Lee, M.K., Eriksson, T., Kessler, B.M., Kramer, H.B., Edelmann, M.J., Willam, C., Pugh, C.W., Schofield, C.J., et al. (2011). Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J. Biol. Chem. 286, 13041-13051.
126. To, K.K.W. and Huang, L.E. (2005). Suppression of hypoxia-inducible factor 1α (HIF-1α ) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J. Biol. Chem. 280, 38102-38107.
127. Vogel, J. and Gassmann, M. (2011). Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J. Physiol. 589, 1259-1264.
128. Walmsley, S.R., Chilvers, E.R., Thompson, A.A., Vaughan, K., Marriott, H.M., Parker, L.C., Shaw, G., Parmar, S., Schneider, M., Sabroe, I., et al. (2011). Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 121, 1053-1063.
129. Wang, J., Chen, G., Muckenthaler, M., Galy, B., Hentze, M.W., and Pantopoulos, K. (2004). Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24, 954-965.
130. Willam, C., Maxwell, P.H., Nichols, L., Lygate, C., Tian, Y.M., Bernhardt, W., Wiesener, M., Ratcliffe, P.J., Eckardt, K.U., and Pugh, C.W. (2006). HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J. Mol. Cell. Cardiol. 41, 68-77.
131. Wottawa, M., Köditz, J., and Katschinski, D.M. (2010). Normoxic destabilization of ATF-4 depends on proteasomal degradation. Acta Physiol. (Oxf) 198, 457-463.
132. Xie, L., Xiao, K., Whalen, E.J., Forrester, M.T., Freeman, R.S., Fong, G., Gygi, S.P., Lefkowitz, R.J., and Stamler, J.S. (2009). Oxygenregulated β2 -adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci. Signal. 2, ra33.
133. Xie, L., Pi, X., Mishra, A., Fong, G., Peng, J., and Patterson, C. (2012). PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. J. Clin. Invest. 122, 2827-2836.
134. Yan, B., Huo, Z., Liu, Y., Lin, X., Li, J., Peng, L., Zhao, H., Zhou, Z.N., Liang, X., Liu, Y., et al. (2011). Prolyl hydroxylase 2: a novel regulator of β2 -adrenoceptor internalization. J. Cell. Mol. Med. 15, 2712-2722.
135. Yu, F., White, S.B., Zhao, Q., and Lee, F.S. (2001). HIF-1α is regulated by stimulus sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
136. Zhang, Q., Gu, J., Li, L., Liu, J., Luo, B., Cheung, H.W., Boehm, J.S., Ni, M., Geisen, C., Root, D.E., et al. (2009). Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell 16, 413-424.